Yahoo Web Search

Search results

1. • 

     European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

     Benzinga· 1 week ago

     Moderna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...

2. • Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier

     Guru Focus· 7 hours ago

     Long-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...

3. • 

     Is This a Setback for Moderna?

     Motley Fool via Yahoo Finance· 2 weeks ago

     Investors have put their hopes in Moderna's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it...

4. • 

     Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?

     Investor's Business Daily· 2 weeks ago

     Moderna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...

5. • Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)

     Benzinga· 2 weeks ago

     Loading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna . Looking at options history for Moderna MRNA ...

6. • 

     Should You Buy This Stock After a Regulatory Setback? | The Motley Fool

     The Motley Fool· 1 day ago

     The past two-and-a-half years have been rough for Moderna (MRNA 1.58%). The company is developing...

7. • 

     Moderna Has Big AI News. Is the Stock a Buy?

     Motley Fool via Yahoo Finance· 5 days ago

     Moderna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this...

8. • 

     Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?

     TipRanks via Yahoo Finance· 1 week ago

     Moderna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again...

9. • 

     Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe

     The Boston Globe· 1 week ago

     Moderna said Friday that the European Patent Office has upheld the validity of one of its key...

10. • 

      Could Novavax Become the Next Moderna?

      Motley Fool via Yahoo Finance· 2 weeks ago

      Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...